Xinting Zhu

Prof. Xinting Zhu

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2024 in Molecules
Verified
Journal Article
Open access
PDF file
KFKelan Fang
Kelan Fang
HZHuiling Zhang
Huiling Zhang
QKQinghong Kong
Qinghong Kong
YMYunli Ma
Yunli Ma
TXTianchan Xiong
Tianchan Xiong
XZXinting Zhu
Xinting Zhu
Photothermal, photodynamic and sonodynamic cancer therapies offer opportunities for precise tumor ablation and reduce side effects. The cyclic guanylate adenylate synthase-stimulator of interferon genes (cGAS-STING) pathway has been considered a potential target to stimulate the immune system in patients and achieve a sustained immune response. Combining photothermal, photodynamic and sonodynamic therapies with cGAS-STING agonists represents a newly developed cancer treatment demonstrating noticeable innovation in its impact on the immune system. Recent reviews have concentrated on diverse materials and their function in cancer therapy. In this review, we focus on the molecular mechanism of photothermal, photodynamic and sonodynamic cancer therapies and the connected role of cGAS-STING agonists in treating cancer.

15 April 2026 in Food Bioscience
Verified
Journal Article
Closed access
FPFENG PAN
FENG PAN
NYNan Yang
Nan Yang
DYDerong Yang
Derong Yang
KLKunmei Li
Kunmei Li
BZBei Zhang
Bei Zhang
XZXinting Zhu
Xinting Zhu

1 October 2025 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
YCYingwen Cui
Yingwen Cui
WYWanhong Yang
Wanhong Yang
WLWuyan Liu
Wuyan Liu
YLYiling Li
Yiling Li
CYChunbo Yu
Chunbo Yu
XZXinting Zhu
Xinting Zhu
Photothermal therapy, photodynamic therapy, and radiotherapy offer the potential for precise tumor ablation with minimal adverse reactions. Myc is an oncogene that plays a critical role in cell growth and tumor development by regulating processes such as cell proliferation, differentiation, apoptosis, and metabolism. It is widely expressed in human cancers and is recognized as one of the potential targets for cancer therapy. Recent studies on the mechanism of Myc suggest that inhibiting its expression can delay cancer onset and progression. With the development of medical technology, photothermal therapy utilizes the photothermal conversion properties of nanomaterials to transform light energy into local high temperatures, thereby ablating tumor cells; photodynamic therapy relies on the synergistic action of photosensitizers, light, and oxygen to generate cytotoxic reactive oxygen species that destroy the structure of tumor cells; radiotherapy uses high-energy rays to precisely damage the DNA double-strands of tumor cells and induce free radical damage. All three therapies have demonstrated unique advantages and remarkable efficacy in the field of cancer treatment, offering new treatment options and survival hopes for cancer patients. Meanwhile, they have also propelled the continuous advancement of cancer treatment from traditional models towards more precise and minimally invasive approaches. In this review, we summarize the principles of photothermal, photodynamic therapy and radiotherapy and their related roles in tumor treatment with Myc inhibitors. We hope this review will provide new sights into cancer treatment related to the Myc gene.